乳腺癌患者非前哨淋巴结转移的预测因素
Predictors of non-sentinel lymph node metastasis in breast cancer patients.
作者信息
Goyal A, Douglas-Jones A, Newcombe R G, Mansel R E
机构信息
Department of Surgery, University of Wales College of Medicine, Cardiff, Wales, UK.
出版信息
Eur J Cancer. 2004 Jul;40(11):1731-7. doi: 10.1016/j.ejca.2004.04.006.
In many patients, the sentinel lymph node (SLN) is the sole site of regional nodal metastasis. This subgroup of patients would not be expected to benefit from completion axillary lymph node dissection (CALND). This study evaluated the factors that may determine the likelihood of additional positive nodes in the axilla in the presence of sentinel node metastasis. A total of 618 breast cancer patients underwent SLN biopsy based on lymphoscintigraphy, intraoperative gamma probe detection, and blue dye mapping using 99mTc-nanocolloid and Patent Blue V injected peritumourally. This was followed by standard axillary node clearance at the same operation. Of the 201 patients with a positive SLN, 105 (52%) patients had no further positive nodes in the axilla, 96 (48%) patients had additional metastasis in non-sentinel lymph nodes (NSLN) upon CALND. In patients with a positive SLN, increasing tumour size and tumour grade significantly increased the frequency of additional positive nodes on univariate analysis. The number of SLNs removed and the number of negative SLNs were significant negative predictors. Increasing tumour burden in the sentinel nodes (determined by the number of positive SLNs) was significantly associated with increasing likelihood of positive NSLNs. Multivariate analysis revealed that the rest of the axilla is more likely to be positive if there are more positive than negative SLNs removed and more likely to be negative otherwise. A group of cases from one centre (Cardiff) were subjected to further detailed analysis. Tumour burden in the positive SLN was assessed by measuring the size of metastasis, percentage replacement of the SLN by tumour and by documenting extracapsular extension (ECE) around the SLN. Of the 64 patients with a positive SLN, 34 (53%) patients had no further positive nodes in the axilla, 30 patients (47%) had additional metastasis in NSLNs upon CALND. Increasing tumour burden in the SLN was associated with additional positive nodes in the axilla. Multivariate analysis revealed that size of the SLN metastasis is the most important predictor of involvement of only the SLN. Overall, in patients with a positive SLN, the difference in the number of positive and negative SLNs removed and size of the metastasis in the SLN, all predicted the frequency of additional positive nodes.
在许多患者中,前哨淋巴结(SLN)是区域淋巴结转移的唯一部位。这类患者预计无法从前哨淋巴结清扫术(CALND)中获益。本研究评估了在前哨淋巴结转移的情况下,可能决定腋窝出现更多阳性淋巴结可能性的因素。共有618例乳腺癌患者接受了基于淋巴闪烁显像、术中γ探针检测以及使用99mTc-纳米胶体和肿瘤周围注射的专利蓝V进行蓝色染料定位的前哨淋巴结活检。随后在同一次手术中进行标准腋窝淋巴结清扫。在201例前哨淋巴结阳性的患者中,105例(52%)患者腋窝中没有其他阳性淋巴结,96例(48%)患者在完成腋窝淋巴结清扫后非前哨淋巴结(NSLN)出现了额外转移。在前哨淋巴结阳性的患者中,单因素分析显示肿瘤大小增加和肿瘤分级升高显著增加了出现额外阳性淋巴结的频率。切除的前哨淋巴结数量和阴性前哨淋巴结数量是显著的负性预测因素。前哨淋巴结中的肿瘤负荷增加(由阳性前哨淋巴结的数量决定)与非前哨淋巴结阳性的可能性增加显著相关。多因素分析显示,如果切除的阳性前哨淋巴结多于阴性前哨淋巴结,腋窝其余部位更有可能为阳性,否则更有可能为阴性。对来自一个中心(加的夫)的一组病例进行了进一步详细分析。通过测量转移灶大小、肿瘤取代前哨淋巴结的百分比以及记录前哨淋巴结周围的包膜外扩展(ECE)来评估阳性前哨淋巴结中的肿瘤负荷。在64例前哨淋巴结阳性的患者中,34例(53%)患者腋窝中没有其他阳性淋巴结,30例(47%)患者在完成腋窝淋巴结清扫后非前哨淋巴结出现了额外转移。前哨淋巴结中的肿瘤负荷增加与腋窝中出现额外阳性淋巴结相关。多因素分析显示,前哨淋巴结转移灶大小是仅前哨淋巴结受累的最重要预测因素。总体而言,在前哨淋巴结阳性的患者中,切除的阳性和阴性前哨淋巴结数量的差异以及前哨淋巴结中的转移灶大小,均能预测出现额外阳性淋巴结的频率。